Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team

SOUTH PLAINFIELD, N.J., Dec. 18, 2013 /PRNewswire/ -- Prolong Pharmaceuticals LLC, a biopharmaceutical company dedicated to developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and mortality, today announced...

Prolong’s approach: Taking on multiple diseasesCompany confident Sanguinate can be difference-maker

Attacking one disease is challenging enough, but what if you can attack a disease that produces multiple disorders? Answering that question motivates Prolong Pharmaceuticals LLC, a South Plainfield biotech company developing...